Although ALT and AST enzymes also increased in animals with NASH, they tended to decrease in β-HPC-treated animals, suggesting that, in addition to fibrosis and steatosis, there was also a reduction in inflammation and necrosis, and this was reflected in an improvement of the functionality of the liver. The gene discussed is GPT; the disease is steatosis.